Parabilis Soared Biggest Biotech: Is It Too Late to Buy?
A record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
Explore which funds have the lowest turnover to help you improve tax efficiency and overall portfolio resilience. Learn how turnover affects returns and where to look for low-turnover options.
26,816 articlesA record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
As AI infrastructure names retreat from spring highs, June market conditions and resilient AI demand are prompting in...
SoFi stock has faced a meaningful hurdle in 2026. This guide breaks down whether the decline represents a temporary s...
A federal judge in Illinois denied CoStar's bid to join the Zillow-MRED-Compass dispute as an amicus. The ruling may ...
Trump’s truth social stake has fallen sharply while his golf properties surge, illustrating a two-track fortune in 2026.
Jim Cramer’s take on Noam Shazeer’s departure from Google to OpenAI spotlights a tightening AI talent war and raises ...
Bot traffic and AI-enabled scams are straining online trust and ad budgets. A new wave of identity tools, including A...
SanDisk and Micron surge on AI memory demand, prompting a renewed debate on whether to buy, sell, or hold as fundamen...
Celebrity fashion moments can become financial talking points. This guide explains how to evaluate, insure, and sell ...
When a blue-chip name like Microsoft moves, it can shake nerves and portfolios. This guide explains why microsoft sto...
Dormant Ethereum addresses moved more than 33,600 ETH, revealing a test of demand around the $1,500 level as ethereum...
NovaCore Technologies enters the second half of 2026 with a multi-year backlog, AI revenue momentum, and cloud growth...